MARKET WIRE NEWS

LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-05-06 18:47:39 ET

LifeMD, Inc. (LFMD)

Q1 2025 Earnings Conference Call

May 6, 2025, 4:30 PM ET

Company Participants

Justin Schreiber - Chairman and CEO

Marc Benathen - Chief Financial Officer

Conference Call Participants

David Larsen - BTIG

Sarah James - Cantor Fitzgerald

Steve Dechert - KeyBanc

Steven Valiquette - Mizuho Securities

Yi Chen - H.C. Wainwright

Anderson Schock - B. Riley Securities

Presentation

Operator

Good afternoon. Thank you for joining us today to discuss LifeMD’s Results for the First Quarter ended March 31, 2025. Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer; and Marc Benathen, Chief Financial Officer. Following management’s prepared remarks, we will open the call for a question-and-answer session.

Before we begin, I would like to remind everyone that during this call, the company will make a number of forward-looking statements, which are subject to numerous risks and uncertainties that may cause actual results to differ materially from those projected. These risks and uncertainties are described in the company’s 10-K and 10-Q filings and within other filings that LifeMD may make with the SEC from time-to-time. Forward-looking statements made during this call are based on current information available to the company as of today, May 6, 2025. The company assumes no obligation to update or revise any forward-looking statements after today’s call except as required by law.

Also, please note that management will be discussing certain non-GAAP financial measures that the company believes are important in evaluating LifeMD’s performance. Details on the relationship between these non-GAAP measures to the most comparable GAAP measures and reconciliations thereof can be found in the press release issued earlier today.

Finally, I would like to remind everyone that today’s call is being recorded and will be available for replay in the Investor Relations section of the company’s website....

Read the full article on Seeking Alpha

For further details see:

LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript
LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock

NASDAQ: LFMDP

LFMDP Trading

1.53% G/L:

$23.25 Last:

173 Volume:

$23.25 Open:

mwn-ir Ad 300

LFMDP Latest News

August 05, 2025 04:05:00 pm
LifeMD Reports Second Quarter 2025 Results

LFMDP Stock Data

$154,725,571
39,278,882
N/A
33
N/A
Healthcare Providers & Services
Healthcare
US
New York

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App